Email this article to a friend
Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)
-
* Corresponding author: Alexander Wall walla@uni-muenster.de
Breast Cancer Research 2008, 10:R23 doi:10.1186/bcr1875